ICER Releases Final Report and Policy Recommendations for Ulcerative Colitis Treatments
The Institute for Clinical and Economic Review (ICER) recently released a Final Evidence Report and Report-at-a-Glance evaluating comparative clinical effectiveness and value of the [...]
Reminder: ICER Webinar on Cost-Recovery Pricing for COVID-19 Drugs is Tomorrow
The first installment of the Institute for Clinical and Economic Review's (ICER) three-part webinar series on drug pricing models for [...]
First Installment in ICER Webinar Series is Friday
The first session of the Institute for Clinical and Economic Review's (ICER) upcoming webinar series is set for Friday, July [...]
ICER Hosting Series on Drug Pricing During a Pandemic
The Institute for Clinical and Economic Review (ICER) is scheduled to host a three-part series focused on drug pricing during [...]
ICER Reschedules CF Meeting
The Institute for Clinical and Economic Review (ICER) has rescheduled its public meeting on cystic fibrosis treatments to Aug. 27. [...]
ICER Outlines Planned Review of High Cholesterol Treatments
The Institute for Clinical and Economic Review (ICER) in a recently-released document outlines its planned review of high cholesterol treatments. [...]
ICER Posts White Paper on Alternative Pricing Policies During Pandemic
The Institute for Clinical and Economic Review (ICER) announced the release of a new white paper on alternative policies for [...]
ICER Cancels Meeting for Non-Alcoholic Steatohepatitis Assessment
The Institute for Clinical and Economic Review (ICER) has canceled the August meeting of the Midwest CEPAC. The meeting was [...]
Reminder: ICER Accepting Comments on Annual Unsupported Price Increase Assessment
The Institute for Clinical and Economic Review (ICER) is accepting public input on the target drugs for this year's Unsupported [...]
ICER to Assess Roxadustat for Treatment Anemia in Chronic Kidney Disease
The Institute for Clinical and Economic Review (ICER) announced plans to assess FibroGen's roxadustat for the treatment of anemia in [...]
Blog Post Touts VA, ICER Partnership as ‘Highly Beneficial’
The partnership between the Department of Veterans Affairs (VA) and the Institute for Clinical and Economic Review (ICER) has provided [...]
Study: ICER Reports Play Major Role in MCOs’ Decisions
Many managed care organizations say they use reports by the Institute for Clinical and Economic Review (ICER) in their decision-making, [...]
ICER Plans Review of Treatments for High Cholesterol
The Institute for Clinical and Economic Review (ICER) announced plans to review Novartis' inclisiran and Esperion Therapeutics' Nexletol for the [...]
ICER to CF Community: ‘We Support Actions to Receive Fair Prices’
The Institute for Clinical and Economic Review (ICER) in a letter to the cystic fibrosis community says it supports fair [...]
How Can Pharma Best Interact with ICER?
A new report from FirstWord looks at how pharma can best engage with the Institute for Clinical and Economic Review [...]
ICER Releases Draft Report on Ulcerative Colitis Therapies
The Institute for Clinical and Economic Review (ICER) recently released a draft evidence report on ulcerative colitis treatments. ICER is [...]
PRMA’s Lodowski Highlights 2020 Updates to ICER’s Value Assessment Framework
PRMA Consulting's Nicole Lodowski in a recent blog post outlines seven key areas that have been updated in the Institute [...]
ICER Posts Report Outlining Planned Review of Supervised Injection Facilities
The Institute for Clinical and Economic Review (ICER) posted a new document outlining a planned review of supervised injection facilities [...]
ICER Appoints New Members to Independent Councils
The Institute for Clinical and Economic Review (ICER) announced new appointments to each of its three independence evidence appraisal councils. [...]
Winegarden: ICER’s Cost Model ‘Wrong,’ ‘Dangerous’
Wayne Winegarden, senior fellow in business and economics at the Pacific Research Institute, says the Institute for Clinical and Economic [...]
ICER’s Venable Focuses on Patient Engagement
Yvette Venable, the Institute for Clinical and Economic Review's (ICER) vice president of patient engagement, is working to foster stronger [...]
ICER: Remdesivir Cost-effective at $4,460
The Institute for Clinical and Economic Review (ICER) has established a starting point for discussion about the price of Gilead's [...]
ICER Taps Campbell as Senior VP for Health Economics
The Institute for Clinical and Economic Review (ICER) on Thursday, April 23, announced the appointment of Jonathan Campbell as the [...]
ICER Names Venable VP of Patient Engagement
The Institute for Clinical and Economic Review (ICER) announced the appointment of Yvette Venable as its first-ever vice president of [...]
Column: Coronavirus Pulls Back Curtain on Health Rationing
In a recent guest column published in the Orlando Sentinel, Sue Peschin, president and CEO of the Alliance for Aging [...]